myelofibrosis with myeloid metaplasia (MMM)
Showing 26 - 50 of 2,707
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston
Completed
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Myelofibrosis Trial in France (Clonal architecture determination)
Not yet recruiting
- Myelofibrosis
- Clonal architecture determination
-
Angers, France
- +6 more
Jan 24, 2023
Endoscopic Grading of Intestinal Metaplasia
Active, not recruiting
- Narrow-band Imaging
- +2 more
- Narrow-band imaging endoscopy
-
Seoul, Korea, Republic ofDigestive Disease Center, Soonchunhyang University Hospital
Jun 28, 2022
Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)
Recruiting
- Myelofibrosis
- Jaktinib
- +3 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022
Pyloric or Pseudopyloric Metaplasia of Corpus Mucosa in
Enrolling by invitation
- Autoimmune Diseases
- +4 more
- Assess pyloric or pseudopyloric metaplasia of corpus by H&E stains
- +2 more
-
Tainan, TaiwanNational Cheng Kung University Hospital
Feb 3, 2022
Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)
Not yet recruiting
- Myelofibrosis
- Moderate Thrombocytopenia
- (no location specified)
Jul 31, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Assess Real-World Patient-Reported Outcomes With Fedratinib for
Recruiting
- Myelofibrosis
-
City, State, AustriaLocal Institution
Dec 16, 2022
Cytosponge for Gastric Intestinal Metaplasia
Not yet recruiting
- Gastric Cancer
- +2 more
- Cytosponge-TFF3
- (no location specified)
Dec 9, 2022
Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)
Recruiting
- Myelofibrosis Due to and Following Polycythemia Vera
-
Basking Ridge, New Jersey
- +6 more
Jan 26, 2023
Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)
Recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablet
-
Canton, OhioSite 01
Aug 18, 2022
Gastric Intestinal Metaplasia, Treatment, Radio-frequency Ablation Trial in Pathum Wan (Radiofrequency ablation (RFA))
Recruiting
- Gastric Intestinal Metaplasia
- +2 more
- Radiofrequency ablation (RFA)
-
Pathum Wan, Bangkok, ThailandRapat Pittayanon
Mar 28, 2022
Barrett's Esophagus, Intestinal Metaplasia Trial in Kaohsiung City (Different biopsy protocol for patients with suspected
Not yet recruiting
- Barrett's Esophagus
- Intestinal Metaplasia
- Different biopsy protocol for patients with suspected Barrett's Esophagus
-
Kaohsiung City, TaiwanE-DA Hospital
Apr 14, 2023
GIM Diagnosis, Artificial Intellegence Trial in Pathum Wan (Artificial intelligence)
Recruiting
- GIM Diagnosis
- Artificial Intellegence
- Artificial intelligence
-
Pathum Wan, Bangkok, ThailandRapat Pittayanon
Mar 28, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)
Recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 21, 2022
Severity of Gastric Intestinal Metaplasia With Pathology
Recruiting
- Gastric Intestinal Metaplasia
- +3 more
- The diagnosis of Artificial Intelligence and pathologists
-
Jinan, Shandong, ChinaDepartment of Gastroenterology, Qilu Hospital, Shandong Universi
Jul 3, 2022
MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- (no location specified)
Nov 29, 2021